Device-Aided Therapies in Parkinson’s Disease—Results from the German Care4PD Study
Brain Sciences · 28.04.2023 · 13 (5) · 736
DOI: 10.3390/brainsci13050736 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Sciences, online erschienen am 28.04.2023. Verfasst von Odette Fründt und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Klinikum Ernst von Bergmann, Charlottenstraße 72, 14467 Potsdam, Germany. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prof. Dr. Klaus Thiemann Stiftung.
Abstract (Originalsprache)
Data on the use of device-aided therapies (DATs) in people with Parkinson’s disease (PwP) are scarce. Analyzing data from the Care4PD patient survey, we (1) evaluated application frequency and type of DAT in a larger, nationwide, cross-sectoral PwP sample in Germany; (2) analyzed the frequency of symptoms indicative for advanced PD (aPD) and need for DAT amongst the remaining patients and (3) compared the most bothersome symptoms and need for professional long-term care (LTC) of patients with and without suspected aPD. Data from 1269 PwP were analyzed. In total, 153 PwP (12%) received DAT, mainly deep brain stimulation (DBS). Of the remaining 1116 PwP without DAT, >50% fulfilled at least one aPD criterion. Akinesia/rigidity and autonomic problems were most bothersome for PwP with and without suspected aPD, with more tremor in the non-aPD and more motor fluctuations and falls in the aPD group. To recapitulate, the German DAT application rate is rather low, although a large proportion of PwP fulfills aPD criteria indicating a need for intensified treatment strategies. Many reported bothersome symptoms could be overcome with DAT with benefits even for LTC patients. Thus, precise and early identification of aPD symptoms (and therapy-resistant tremor) should be implemented in future DAT preselection tools and educational trainings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Klinikum Ernst von Bergmann, Charlottenstraße 72, 14467 Potsdam, Germany.
- Transversal Translational Medicine, Luxembourg Institute of Health (LIH), 1A-B, Rue Thomas Edison, L-1445 Strassen, Luxembourg.
- Faculty of Science, Technology and Medicine, University of Luxembourg, Belval Campus, Maison du Savoir, 2 Avenue de l'Université, L-4365 Esch-sur-Alzette, Luxembourg.
- Department of Epidemiology, CAPHRI School for Public Health and Primary Care, Maastricht University Medical Centre, Postbus 5800, 6202 AZ Maastricht, The Netherlands.
- Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
- Department of Nursing Development/Nursing Research, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany.
ORCID-Profile: Anne-Marie Hanff
Förderung
- Prof. Dr. Klaus Thiemann Stiftung
Zitieren
APA
Fründt, O., Hanff, A. M., Möhl, A., Mai, T., Kirchner, C., Amouzandeh, A., Buhmann, C., Krüger, R., & Südmeyer, M. (2023). Device-Aided Therapies in Parkinson’s Disease—Results from the German Care4PD Study. Brain Sciences, 13(5), 736. https://doi.org/10.3390/brainsci13050736
Vancouver
Fründt O, Hanff AM, Möhl A, Mai T, Kirchner C, Amouzandeh A, et al. Device-Aided Therapies in Parkinson’s Disease—Results from the German Care4PD Study. Brain Sciences. 2023;13(5):736. doi:10.3390/brainsci13050736
BibTeX
@article{Frndt2023,
author = {Fründt, Odette and Hanff, Anne-Marie and Möhl, Annika and Mai, Tobias and Kirchner, Christiane and Amouzandeh, Ali and Buhmann, Carsten and Krüger, Rejko and Südmeyer, Martin},
title = {Device-Aided Therapies in Parkinson’s Disease—Results from the German Care4PD Study},
journal = {Brain Sciences},
year = {2023},
volume = {13},
number = {5},
pages = {736},
doi = {10.3390/brainsci13050736}
}
EUVIMED